PRN2- COST-EFFECTIVENESS OF BASILIXIMAB, DACLIZUMAB, AND OKT3 AS INDUCTION AGENTS IN KIDNEY TRANSPLANTATION
Mar 1, 2000, 00:00
10.1016/S1098-3015(11)70550-2
https://www.valueinhealthjournal.com/article/S1098-3015(11)70550-2/fulltext
Title :
PRN2- COST-EFFECTIVENESS OF BASILIXIMAB, DACLIZUMAB, AND OKT3 AS INDUCTION AGENTS IN KIDNEY TRANSPLANTATION
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(11)70550-2&doi=10.1016/S1098-3015(11)70550-2
First page :
Section Title :
Open access? :
No
Section Order :
103